Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: This study aimed to investigate the impact of comorbidity on cognitive and functional decline in patients with Alzheimer dementia (AD). Methods: One hundred and two AD outpatients examined at the Psychiatry Department of the CF2 Polyclinic in Bucharest, Romania and re‐evaluated after 2 years. Comorbidity was rated using the Cumulative Illness Rating Scale for Geriatrics (CIRS‐G). Results: Baseline mean age (SD) was 75.4 (8.2) years, median CDR (range) was 2 (1–3), and mean MMSE (SD) 14.2 (4.9). MMSE declined to 11.2 (4.8) during follow‐up. Baseline mean total CIRS‐G score (SD) was 13.8 (5.4), median number of endorsed categories (range) was 8 (1–14), and mean severity index (SD) 1.9 (0.4). Main comorbidity areas were cardiovascular, ear, nose and throat, genitourinary, musculoskeletal/integument, and neurological. Severity of comorbidity increased with dementia severity (p < 0.001). Baseline comorbidity was related to increased rate of cognitive decline; truncated regression coefficients (p‐values) were 0.01 (0.02) for CIRS‐G total score, and 0.15 (0.006) for severity index (controlled for age, sex, education, and AD treatment). Faster cognitive decline was associated with faster functional decline: OR (95% CI) was 5.2 (1.9−13.6) for increased rate of ADL change and 3.8 (1.0−14.1) for increased rate of IADL change (controlled for age, sex, education, AD medication, and comorbidity). Comorbidity tended to increase functional decline; however, the associations were not statistically significant. Conclusions: In this group of patients with AD, comorbidity increased the rate of cognitive decline. Considering comorbidity instead of focusing on separate conditions may be more helpful in managing AD. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · cited 1×
“Concomitant cerebrovascular lesions increase the risk (Snowdon et al., 1997) and severity (Heyman et al., 1998) of clinical dementia in patients meeting neuropathological criteria for AD, and it seems that AD and vascular disease may work synergistically to cause cognitive decline (Iadecola, 2010).”
BackgroundThe overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557 · cited 4×
“Concomitant cerebrovascular lesions increase the risk (Snowdon et al., 1997) and severity (Heyman et al., 1998) of clinical dementia in patients meeting neuropathological criteria for AD, and it seems that AD and vascular disease may work synergistically to cause cognitive decline (Iadecola, 2010).”
BackgroundInfluentialPromising Strategies for the Prevention of Dementia
Middleton, L. E., & Yaffe, K. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.201 · Cited by 396 · cited 2×
“…atherosclerosis, myocardial infarction, atrial fibrillation, diabetes) have been linked to increased risk of dementia and Alzheimer disease (AD) (Middleton and Yaffe, 2009), but their role as predictors of faster cognitive decline after dementia onset has been less investigated and results are…”
ResultChanging perspectives regarding late-life dementia
Fotuhi, M., Hachinski, V., & Whitehouse, P. J. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.175 · Cited by 291
Portet, F., Scarmeas, N., Cosentino, S., Helzner, E. P., & Stern, Y. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.196 · Cited by 79 · cited 2×
“Motor signs (Scarmeas et al., 2005; Portet et al., 2009) and delirium (Fong et al., 2009) have also been reported to accelerate cognitive decline in AD.”
BackgroundCarotid atherosclerosis and cognitive decline in patients with Alzheimer's disease
Silvestrini, M., Gobbi, B., Pasqualetti, P., Bartolini, M., Baruffaldi, R., Lanciotti, C., Cerqua, R., Altamura, C., Provinciali, L., & Vernieri, F. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.008 · Cited by 78 · cited 2×
“, hypertension, hypercholesterolemia, atherosclerosis, myocardial infarction, atrial fibrillation, diabetes) have been linked to increased risk of dementia and Alzheimer disease (AD) (Middleton and Yaffe, 2009), but their role as predictors of faster cognitive decline after dementia onset has been less investigated an…”
ResultAppelman, A. P. A., Vincken, K. L., van der Graaf, Y., Vlek, A. L. M., Witkamp, T. D., Mali, W. P. T. M., & Geerlings, M. I. (2010) · Cerebrovascular Diseases · doi:10.1159/000255971 · Cited by 58 · cited 1×
“Vascular factors have been linked to cerebral atrophy, and atrophy was suggested to result from ischemic damage (Appelman et al., 2010).”
Background
Cited by
Comorbidity of dementia: a cross-sectional study of primary care older patients
Poblador-Plou, B., Calderón-Larrañaga, A., Marta-Moreno, J., Hancco-Saavedra, J., Sicras-Mainar, A., Soljak, M., & Prados-Torres, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-84 · Cited by 256
Browne, J., Edwards, D. A., Rhodes, K. M., Brimicombe, D. J., & Payne, R. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012546 · Cited by 186
Fabbri, E., An, Y., Zoli, M., Tanaka, T., Simonsick, E. M., Kitner‐Triolo, M. H., Studenski, S. A., Resnick, S. M., & Ferrucci, L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14092 · Cited by 123
The influence of multimorbidity on clinical progression of dementia in a population-based cohort
Melis, R. J. F., Marengoni, A., Rizzuto, D., Teerenstra, S., Kivipelto, M., Angleman, S. B., & Fratiglioni, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084014 · Cited by 96
“On other hand, empirical studies in dementia patients have also shown that over longer follow ups – as we had in our study – MMSE does capture cognitive change [31] and MMSE has been used previously for studying heterogeneity in cognitive trajectories in persons with dementia [12,13].”
BackgroundMedical Comorbidities of Dementia: Links to Caregivers' Emotional Difficulties and Gains
Polenick, C. A., Min, L., & Kales, H. C. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16244 · Cited by 33
Metadata
- Authors
- Solomon, A., Dobranici, L., Kåreholt, I., Tudose, C., & Lăzărescu, M.
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2011-04-16
- Volume
- 26
- Issue
- 12
- Pages
- 1244-1251
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W2010340673
- Cited by
- 68
- References
- 7
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia. https://app.cochat.ai/papers/10.1002/gps.2670
- The paper
- Solomon, A., Dobranici, L., Kåreholt, I., Tudose, C., & Lăzărescu, M. (2011). Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.2670
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.